Research Study Comparing a New Medicine "Fast-acting Insulin Aspart" to Another Already Available Medicine "NovoRapid"/"NovoLog" in People With Type 2 Diabetes
Public ClinicalTrials.gov record NCT03268005. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Efficacy and Safety of Fast-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec With or Without Metformin in Adults With Type 2 Diabetes (Onset® 9)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study compares 2 medicines for type 2 diabetes: fast-acting insulin aspart (a new medicine) and NovoRapid®/NovoLog® (a medicine doctors can already prescribe). Fast-acting insulin aspart will be tested to see how well it works and if it is safe. Participants will get either fast-acting insulin aspart or NovoRapid®/ NovoLog® - which treatment you get is decided by chance. Both medicines will be taken together with insulin degludec. Participants will need to take 1 injection 4 times every day (all insulins will be provided in pens). The study will last for about 8 months (34 weeks).
Study identification
- NCT ID
- NCT03268005
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,264 participants
Conditions and interventions
Conditions
Interventions
- Faster-acting insulin aspart Drug
- Insulin aspart Drug
- Insulin degludec Drug
- Metformin Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 19, 2017 (Actual)
- Primary completion
- Jan 7, 2019 (Actual)
- Completion
- Jan 29, 2019 (Actual)
- Last update posted
- Jan 11, 2022
2017 – 2019
United States locations
- U.S. sites
- 64
- U.S. states
- 28
- U.S. cities
- 59
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novo Nordisk Investigational Site | Concord | California | 94520 | — |
| Novo Nordisk Investigational Site | Fresno | California | 93720 | — |
| Novo Nordisk Investigational Site | Fullerton | California | 92835 | — |
| Novo Nordisk Investigational Site | Lancaster | California | 93534 | — |
| Novo Nordisk Investigational Site | Norco | California | 92860 | — |
| Novo Nordisk Investigational Site | Sacramento | California | 95821 | — |
| Novo Nordisk Investigational Site | Ventura | California | 93003 | — |
| Novo Nordisk Investigational Site | Walnut Creek | California | 94598 | — |
| Novo Nordisk Investigational Site | Denver | Colorado | 80246 | — |
| Novo Nordisk Investigational Site | Golden | Colorado | 80401 | — |
| Novo Nordisk Investigational Site | Waterbury | Connecticut | 06708 | — |
| Novo Nordisk Investigational Site | Boynton Beach | Florida | 33472 | — |
| Novo Nordisk Investigational Site | Bradenton | Florida | 34201 | — |
| Novo Nordisk Investigational Site | Fort Lauderdale | Florida | 33312 | — |
| Novo Nordisk Investigational Site | Miami | Florida | 33174 | — |
| Novo Nordisk Investigational Site | Tampa | Florida | 33634 | — |
| Novo Nordisk Investigational Site | Alpharetta | Georgia | 30022 | — |
| Novo Nordisk Investigational Site | Lawrenceville | Georgia | 30046 | — |
| Novo Nordisk Investigational Site | Roswell | Georgia | 30076 | — |
| Novo Nordisk Investigational Site | Honolulu | Hawaii | 96814 | — |
| Novo Nordisk Investigational Site | Chicago | Illinois | 60611 | — |
| Novo Nordisk Investigational Site | Peoria | Illinois | 61603 | — |
| Novo Nordisk Investigational Site | Springfield | Illinois | 62711 | — |
| Novo Nordisk Investigational Site | Valparaiso | Indiana | 46383 | — |
| Novo Nordisk Investigational Site | West Des Moines | Iowa | 50266 | — |
| Novo Nordisk Investigational Site | Topeka | Kansas | 66606 | — |
| Novo Nordisk Investigational Site | Lexington | Kentucky | 40502 | — |
| Novo Nordisk Investigational Site | Lexington | Kentucky | 40503 | — |
| Novo Nordisk Investigational Site | Rockville | Maryland | 20852 | — |
| Novo Nordisk Investigational Site | Waltham | Massachusetts | 02453 | — |
| Novo Nordisk Investigational Site | Worcester | Massachusetts | 01655 | — |
| Novo Nordisk Investigational Site | Henderson | Nevada | 89052-2649 | — |
| Novo Nordisk Investigational Site | Las Vegas | Nevada | 89148 | — |
| Novo Nordisk Investigational Site | Nashua | New Hampshire | 03063 | — |
| Novo Nordisk Investigational Site | Northport | New York | 11768 | — |
| Novo Nordisk Investigational Site | West Seneca | New York | 14224 | — |
| Novo Nordisk Investigational Site | Asheville | North Carolina | 28803 | — |
| Novo Nordisk Investigational Site | Chapel Hill | North Carolina | 27514 | — |
| Novo Nordisk Investigational Site | Mentor | Ohio | 44060 | — |
| Novo Nordisk Investigational Site | Oklahoma City | Oklahoma | 73104-5020 | — |
| Novo Nordisk Investigational Site | Philadelphia | Pennsylvania | 19140 | — |
| Novo Nordisk Investigational Site | Greenville | South Carolina | 29605-4254 | — |
| Novo Nordisk Investigational Site | Chattanooga | Tennessee | 37404 | — |
| Novo Nordisk Investigational Site | Chattanooga | Tennessee | 37411 | — |
| Novo Nordisk Investigational Site | Nashville | Tennessee | 37212 | — |
| Novo Nordisk Investigational Site | Amarillo | Texas | 79106 | — |
| Novo Nordisk Investigational Site | Austin | Texas | 78731 | — |
| Novo Nordisk Investigational Site | Austin | Texas | 78749 | — |
| Novo Nordisk Investigational Site | Beaumont | Texas | 77701 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75226 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75230 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75231 | — |
| Novo Nordisk Investigational Site | Longview | Texas | 75605 | — |
| Novo Nordisk Investigational Site | Pearland | Texas | 77584 | — |
| Novo Nordisk Investigational Site | Round Rock | Texas | 78681 | — |
| Novo Nordisk Investigational Site | Ogden | Utah | 84405 | — |
| Novo Nordisk Investigational Site | Bennington | Vermont | 05201 | — |
| Novo Nordisk Investigational Site | South Burlington | Vermont | 05403 | — |
| Novo Nordisk Investigational Site | Chesapeake | Virginia | 23321 | — |
| Novo Nordisk Investigational Site | Winchester | Virginia | 22601-3834 | — |
| Novo Nordisk Investigational Site | Olympia | Washington | 98502 | — |
| Novo Nordisk Investigational Site | Seattle | Washington | 98105 | — |
| Novo Nordisk Investigational Site | Spokane | Washington | 99201 | — |
| Novo Nordisk Investigational Site | Green Bay | Wisconsin | 54303 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 103 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03268005, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 11, 2022 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03268005 live on ClinicalTrials.gov.